Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.
Atripla, switched to Truvada + Isentress
Jun 18, 2009
I first started treatment with Atripla and was on it for two months. It had a dramatic effect in reducing VL from 80K to 150 in those two months. Problem was, I was not doing well with Sustiva side effect; very sleepy/tired during the day, hard to fall asleep at night. Taking it on an empty stomach really put a crimp in my eating habits. Doc switched me to Truvada plus Isentress. I feel GREAT, no appreciable side effect at all. Now my question. Do you think the combo of Truvada + Isentress is just as durable, or should I have stayed on Atripla and just put up with it?
Thanks for your opinion.
Advertisement
Response from Dr. Young
Hello and thanks for your post.
First off, I'll say that it's my philosophy that patients shouldn't have to "put up" with intolerable side effects. We have too many good and well tested HIV medications for this to be the case.
So, while Atripla (tenofovir/FTC/efavirenz) is very well tolerated and very convenient for the majority of patients, there are some persons who find that it's not that for them. If your having difficulty with sleep and fatigue and diet changes after two months, it's hard for me to believe that they'll get much better in the short term- therefore a switch does seem reasonable.
I'm glad to hear that your symptoms improved after the switch from the Atripla to Truvada (tenofovir/FTC) with raltegravir (Isentress). If you don't have any previous issues with HIV drug resistance, this change should improve the central nervous system side effects and be very durable. Details of the STARTMRK study that compared efavirenz to raltegravir can be found in this
TheBodypro.com review by Dr. David Wohl. My only reservation about changes to raltegravir would be among persons who have compromised potency of their NRTI components (in your case, tenofovir/FTC)- as was shown in a recent study called SWITCHMRK.
I hope this helps.
Be well,
BY
Want to read more questions and answers on this subject? Our experts have answered many similar questions!
Please remember that this forum is designed for educational purposes only, and experts are not engaged through this
forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible
for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.
Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this
forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or
edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their
messages.
Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as
legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a
health or legal problem, you should consult your own health care provider or your attorney.